Sun Pharma Advanced has target of Rs 74: Aunali Rupani

Sun Pharma Advanced has target of Rs 74, says Aunali Rupani, Director of Arm Research.

Rupani told CNBC-TV18, "Sun Pharma Advanced Research Company has recently done a JV with Merck. They have announced a rights issue of almost Rs 200 crore. There will be a dilution of close to 20% and the rights issue will come at the price of close to Rs 50 per share. This is a portfolio stock to be kept for 3-5 years. My target for the day will be Rs 74 and stop loss at Rs 69." Click HERE to know the rules and follow the score card